Company intelligence / Profile preview

Stem Cells For Hope

Sugar Land, Texas, USAlibn.com ↗

Ownership: Private
Employees: ~12
Development stage: Commercial

Overview

Hope Biosciences has reported promising results from a Phase 2 trial in multiple sclerosis showing significant improvements in quality-of-life scores. The company is also running or has run trials in Alzheimer's disease, Long COVID, and other neurological or degenerative conditions. Their approach uses high-dose, fresh autologous adipose-derived mesenchymal stem cells expanded using proprietary methods to ensure consistency and repeat dosing. Safety profile appears favorable so far.

Therapeutic areas: RheumatologyNeurologyInfectious Diseases
Modalities: Stem cell therapyCell therapy
Industry: Biotech

Partnerships

Altoida Inc. – digital biomarker partnership for Alzheimer's clinical trials

Beyond the preview

Go deeper on Stem Cells For Hope.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stem Cells For Hope.

Explore the full profile